Literature DB >> 1511160

The effect of phlebotomy on serum erythropoietin levels in normal healthy subjects.

H Maeda1, Y Hitomi, R Hirata, H Tohyama, J Suwata, S Kamata, Y Fujino, N Murata.   

Abstract

We evaluated endogenous serum erythropoietin (Epo) levels in 14 normal subjects (eight males and six females) after a single 400-ml phlebotomy. The subjects were followed up for 56 days. The hemoglobin (Hb) values of both males and females decreased to a nadir on days 3 to 7 post-phlebotomy. Hb values gradually increased, but did not completely recover to pre-phlebotomy levels by day 56. Serum Epo levels increased after 6 h post-phlebotomy, to 20.1 +/- 5.4 (mU/ml) in males and 20.7 +/- 7.0 in females, from the pre-phlebotomy levels of 14.6 +/- 4.0 in males and 13.4 +/- 4.1 in females, respectively. Epo levels continued to increase to peak levels of 25.5 +/- 6.3 in males and 28.7 +/- 11.5 in females on days 7 to 14 and thereafter decreased until day 56. Thus, the Epo response to a 400-ml phlebotomy was relatively small in magnitude and was not sufficient to initiate a significant increase in erythropoiesis. This finding suggests that the administration of recombinant human erythropoietin (rHu-Epo) may be effective for the prompt correction of anemia induced by autologous blood donation and for increasing the volume of predonated autologous blood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511160

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  5 in total

1.  Phase II open label trial of imatinib in polycythemia rubra vera.

Authors:  C Michael Jones; Tina M Dickinson; August Salvado
Journal:  Int J Hematol       Date:  2008-11-15       Impact factor: 2.490

2.  Trace levels of innate immune response modulating impurities (IIRMIs) synergize to break tolerance to therapeutic proteins.

Authors:  Daniela Verthelyi; Vivian Wang
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

3.  Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.

Authors:  Reza Rastmanesh
Journal:  Int J Gen Med       Date:  2011-09-06

4.  Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women.

Authors:  Nicole U Stoffel; Christophe Zeder; Gary M Brittenham; Diego Moretti; Michael B Zimmermann
Journal:  Haematologica       Date:  2019-08-14       Impact factor: 9.941

5.  Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients.

Authors:  Robert Provenzano; James Tumlin; Raja Zabaneh; James Chou; Stefan Hemmerich; Thomas B Neff; K-H Peony Yu
Journal:  J Clin Pharmacol       Date:  2020-06-30       Impact factor: 3.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.